Chris Ogden
Chief Financial Officer, Cytomics Therapeutics
Replay available
CytomX Therapeutics, Inc. (CTMX) Q1 2026 Earnings Call
CytomX Therapeutics, Inc. (NASDAQ: CTMX) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Sean McCarthy
Chief Executive Officer and Chairman, Cytomics Therapeutics
Paul Jing
Analyst, Guggenheim
Edward Tintoff
Analyst, Piper Sandler
Joy Son
Analyst, J.P. Morgan
Olivia Breyer
Analyst, Cantor Fitzgerald
Matt Bigler
Analyst, Oppenheimer & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cytomx Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.454 Good afternoon, everyone. Thank you for standing by. 00:00:02.454 -- 00:00:07.539 Welcome to the Cytomics Therapeutics first quarter 2026 financial results 00:00:07.539 -- 00:00:11.964 call. Please be advised that today's conference is being recorded. 00:00:11.964 -- 00:00:16.369 I would now like to hand the call over to your host for today, Chris Ogden, Cytomics 00:00:16.369 -- 00:00:18.371 Chief Financial Officer. Please go ahead. 00:00:18.371 -- 00:00:20.371 Thank 00:00:21.154 -- 00:00:24.237 you. Good afternoon, and thank you for joining us. 00:00:24.237 -- 00:00:28.462 Before we begin, I would like to remind everyone that during this call, we will be making 00:00:28.462 -- 00:00:33.587 four looking statements. Because forward-looking statements relate to the future, they're 00:00:33.587 -- 00:00:38.273 subject to inherent uncertainties and risks that are difficult to predict, and many of 00:00:38.273 -- 00:00:40.917 which are outside of our control. 00:00:40.917 -- 00:00:45.623 Important risks and uncertainties are set forth in our most recent public filings with 00:00:45.623 -- 00:00:48.447 the SEC at sec.gov. 00:00:48.447 -- 00:00:53.093 We undertake no obligation to update any forward-looking statements, whether as a result 00:00:53.093 -- 00:00:57.338 of new information, future developments, or otherwise. 00:00:57.338 -- 00:01:01.424 Earlier this afternoon, we issued a press release that includes a summary of our first 00:01:01.424 -- 00:01:07.632 quarter, 2026, financial results, and highlights recent progress at Cytomix. 00:01:07.632 -- 00:01:12.419 We encourage everyone to read today's press release and the associated materials, which 00:01:12.419 -- 00:01:15.423 have been filed with the SEC. 00:01:15.423 -- 00:01:21.01...